CHARACTERIZATION OF THE BINDING AND CHIRAL SEPARATION OF D-TRYPTOPHAN AND L-TRYPTOPHAN ON A HIGH-PERFORMANCE IMMOBILIZED HUMAN SERUM-ALBUMIN COLUMN

被引:0
作者
JU, Y [1 ]
HAGE, DS [1 ]
机构
[1] UNIV NEBRASKA,DEPT CHEM,738 HAMILTON HALL,LINCOLN,NE 68588
来源
JOURNAL OF CHROMATOGRAPHY | 1993年 / 645卷 / 02期
关键词
D O I
暂无
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
High-performance affinity chromatography was used to study the separation and binding of D- and L-tryptophan on an immobilized human serum albumin (HSA) column. Frontal analysis and zonal elution studies indicated that both D- and L-tryptophan were binding to single but distinct sites on HSA. L-Tryptophan bound to the indole site of HSA. D-Tryptophan had indirect interactions with the warfarin site of HSA but no interactions with the indole site. The association constants for the binding Of D- and L-tryptophan at pH 7.4 and 25-degrees-C were 0.4.10(4) and 2.7 - 10(4) M-1, respectively. The value of DELTAG for these sites ranged from -5.2 to -5.7 kcal/mol (1 cal = 4.184 J) and had a significant entropy component. The effects of varying the pH, phosphate concentration, temperature and polarity of the mobile phase on the binding Of D- and L-tryptophan to HSA were examined. The role of sample size in determining peak shape and retention was also considered. From these data, general guidelines were developed for the separation of D- and L-tryptophan on immobilized HSA. Under optimized conditions the enantiomers were separated in less than 2 min with baseline resolution.
引用
收藏
页码:241 / 250
页数:10
相关论文
共 34 条
[21]  
MULLER WE, 1986, DRUG PROTEIN BINDING, pCH2
[22]  
NEWTON P, 1991, LC GC-MAG SEP SCI, V9, P208
[23]  
ROSE WC, 1954, J BIOL CHEM, V211, P815
[24]  
Siggia S., 1979, QUANTITATIVE ORGANIC, P42
[25]  
Sjoholm I., 1986, DRUG PROTEIN BINDING
[26]  
SJOHOLM I, 1978, P FEBS M, V50, P71
[27]   MEASUREMENT OF PROTEIN USING BICINCHONINIC ACID [J].
SMITH, PK ;
KROHN, RI ;
HERMANSON, GT ;
MALLIA, AK ;
GARTNER, FH ;
PROVENZANO, MD ;
FUJIMOTO, EK ;
GOEKE, NM ;
OLSON, BJ ;
KLENK, DC .
ANALYTICAL BIOCHEMISTRY, 1985, 150 (01) :76-85
[28]   CHIRAL DRUGS [J].
STINSON, SC .
CHEMICAL & ENGINEERING NEWS, 1992, 70 (39) :46-&
[29]  
SUDLOW G, 1976, MOL PHARMACOL, V12, P1052
[30]  
SUDLOW G, 1975, MOL PHARMACOL, V11, P824